Jason A. Okazaki - Mar 28, 2022 Form 4 Insider Report for ASSEMBLY BIOSCIENCES, INC. (ASMB)

Role
Chief Operating Officer
Signature
/s/ John O. Gunderson, as Attorney-in-Fact
Stock symbol
ASMB
Transactions as of
Mar 28, 2022
Transactions value $
-$10,363
Form type
4
Date filed
3/29/2022, 07:33 PM
Next filing
Mar 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASMB Common Stock Sale -$10.4K -4.62K -6.67% $2.24 64.6K Mar 28, 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.21 to $2.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
F3 Includes an aggregate of 2,000 shares acquired under the Assembly Biosciences, Inc. 2018 Employee Stock Purchase Plan, with 1,000 shares purchased on May 14, 2021 and 1,000 shares purchased on November 14, 2021.